Articles with public access mandates - Renan Pedra de SouzaLearn more
Not available anywhere: 16
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis
MN Sicard, CC Zai, AK Tiwari, RP Souza, HY Meltzer, JA Lieberman, ...
Pharmacogenomics 11 (11), 1561-1571, 2010
Mandates: Canadian Institutes of Health Research
Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
DJ Müller, CC Zai, M Sicard, E Remington, RP Souza, AK Tiwari, ...
The pharmacogenomics journal 12 (2), 156-164, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
GCM Zai, CCH Zai, NI Chowdhury, AK Tiwari, RP Souza, JA Lieberman, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (1), 96-101, 2012
Mandates: Canadian Institutes of Health Research
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
RP Souza, MA Romano-Silva, JA Lieberman, HY Meltzer, AHC Wong, ...
Psychopharmacology 200, 177-186, 2008
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia
RP Souza, V De Luca, HY Meltzer, JA Lieberman, JL Kennedy
Pharmacogenetics and genomics 20 (4), 274-276, 2010
Mandates: Canadian Institutes of Health Research
Gene–gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response
R Hwang, RP Souza, AK Tiwari, CC Zai, DJ Müller, SG Potkin, ...
Pharmacogenomics 12 (2), 277-291, 2011
Mandates: Canadian Institutes of Health Research
Analysis of CpG SNPs in 34 genes: association test with suicide attempt in schizophrenia
A Bani-Fatemi, VF Gonçalves, C Zai, R de Souza, B Le Foll, JL Kennedy, ...
Schizophrenia research 147 (2-3), 262-268, 2013
Mandates: Canadian Institutes of Health Research
Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour
C Pinto, RP Souza, D Lioult, M Semeralul, JL Kennedy, JJ Warsh, ...
European archives of psychiatry and clinical neuroscience 261, 533-538, 2011
Mandates: Canadian Institutes of Health Research
Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour
V De Luca, RP Souza, CC Zai, F Panariello, N Javaid, J Strauss, ...
The World Journal of Biological Psychiatry 12 (1), 42-47, 2011
Mandates: Canadian Institutes of Health Research
The role of tyrosine hydroxylase gene variants in suicide attempt in schizophrenia
J Hu, LF Chan, RP Souza, M Tampakeras, JL Kennedy, C Zai, V De Luca
Neuroscience letters 559, 39-43, 2014
Mandates: Canadian Institutes of Health Research
Cocaine and amphetamine regulated transcript (CART) gene in the comorbidity of schizophrenia with alcohol use disorders and nicotine dependence
A Busto, RP Souza, DSS Lobo, SA Shaikh, LA Zawertailo, UE Busto, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (6), 834-836, 2010
Mandates: Canadian Institutes of Health Research
Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia
RP Souza, V De Luca, G Remington, JA Lieberman, HY Meltzer, ...
Psychopharmacology 210, 347-354, 2010
Mandates: Canadian Institutes of Health Research
Are serotonin 3A and 3B receptor genes associated with suicidal behavior in schizophrenia subjects?
RP Souza, V De Luca, M Manchia, JL Kennedy
Neuroscience letters 489 (3), 137-141, 2011
Mandates: Canadian Institutes of Health Research
Lack of association between dopamine-β hydroxylase gene and a history of suicide attempt in schizophrenia: comparison of molecular and statistical haplotype analyses
AS Howe, T Leung, A Bani-Fatemi, R Souza, M Tampakeras, C Zai, ...
Psychiatric genetics 24 (3), 110-115, 2014
Mandates: Canadian Institutes of Health Research
Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia
RP Souza, G Remington, HY Meltzer, JA Lieberman, JL Kennedy, ...
International clinical psychopharmacology 25 (5), 264-269, 2010
Mandates: Canadian Institutes of Health Research
“GSK3B and schizophrenia: a case not closed” reply
RP Souza, DL Levy, JL Kennedy
Psychopharmacology 208, 335-336, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Available somewhere: 32
Evolution and epidemic spread of SARS-CoV-2 in Brazil
DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ...
Science 369 (6508), 1255-1260, 2020
Mandates: National Fund for Scientific Research, Belgium, Department of International …
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
AK Tiwari, CC Zai, O Likhodi, A Lisker, D Singh, RP Souza, P Batra, ...
Neuropsychopharmacology 35 (6), 1315-1324, 2010
Mandates: Canadian Institutes of Health Research
Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects
DSS Lobo, RP Souza, RP Tong, DM Casey, DC Hodgins, GJ Smith, ...
Biological psychology 85 (1), 33-37, 2010
Mandates: Canadian Institutes of Health Research
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
RP Souza, V De Luca, HY Meltzer, JA Lieberman, JL Kennedy
International Journal of Neuropsychopharmacology 13 (6), 793-798, 2010
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program